Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3010-3020

  Bobbala, D ^a   Chen, X L ^a   Leblanc, C ^a   Mayhue, M ^a   Stankova, J ^a,b   Tanaka, T ^c   Chen, Y G ^d   Ilangumaran, S ^a,b   Ramanathan, S ^a,b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b Centre Hospitalier Universitaire de Sherbrooke   (Canada)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

IL 15; Insulitis; NOD mice; Type 1 diabetes

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 15; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETOGENESIS; DISEASE MODEL; FEMALE; INCIDENCE; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL SURVIVAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-15; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PREDIABETIC STATE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84867571600     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2675-1     Document Type: Article

References (50)

1. Fehniger TA, Caligiuri MA (2001) Interleukin 15: Biology and relevance to human disease. Blood 97:14-32
2. Waldmann TA, Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 17:19-49
3. Ohteki T, Suzue K, Maki C, Ota T, Koyasu S (2001) Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat Immunol 2:1138-1143
4. Dubois SP, Waldmann TA, Muller JR (2005) Survival adjustment of mature dendritic cells by IL-15. Proc Natl Acad Sci U S A 102:8662-8667
5. Ohteki T, Tada H, Ishida K et al (2006) Essential roles of DCderived IL-15 as a mediator of inflammatory responses in vivo. J Exp Med 203:2329-2338
6. Ruckert R, Brandt K, Bulanova E, Mirghomizadeh F, Paus R, Bulfone-Paus S (2003) Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses. Eur J Immunol 33:3493-3503
7. McInnes IB, al-Mughales J, Field M et al (1996) The role of interleukin-15 in T cell migration and activation in rheumatoid arthritis. Nat Med 2:175-182
8. Meresse B, Chen Z, Ciszewski C et al (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21:357-366
9. Signore A, Annovazzi A, Giacalone P et al (2003) Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice. Diabetes Metabol Res Rev 19:464-468
10. Xia J, Liu W, Hu B, Tian Z, Yang Y (2010) IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice. Clin Immunol 134:130-139
11. Kennedy MK, Glaccum M, Brown SN et al (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191:771-780
12. Carnaud C, Gombert J, Donnars O, Garchon H, Herbelin A (2001) Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J Immunol 166:2404-2411
13. Sharif S, Arreaza GA, Zucker P et al (2001) Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 7:1057-1062
14. Alba A, Planas R, Clemente X et al (2008) Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta. Clin Exp Immunol 151:467-475
15. Angstetra E, Graham KL, Zhao Y et al (2012) An indirect role for NK cells in a CD4(+) T cell-dependent mouse model of type I diabetes. Immunol Cell Biol 90:243-247
16. Poirot L, Benoist C, Mathis D (2004) Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci U S A 101:8102-8107
17. Koulmanda M, Budo E, Bonner-Weir S et al (2007) Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A 104:13074-13079
18. Ramanathan S, Dubois S, Chen XL, Leblanc C, Ohashi PS, Ilangumaran S (2011) Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes. J Immunol 186:5131-5141
19. Li DS, Yuan YH, Tu HJ, Liang QL, Dai LJ (2009) A protocol for islet isolation from mouse pancreas. Nat Protoc 4:1649-1652
20. Tanaka T, Kitamura F, Nagasaka Y, Kuida K, Suwa H, Miyasaka M (1993) Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 178:1103-1107
21. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P (1997) Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186:1663-1676
22. Lieberman SM, Evans AM, Han B et al (2003) Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A 100:8384-8388
23. Trudeau JD, Kelly-Smith C, Verchere CB et al (2003) Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111:217-223
24. Lodolce JP, Boone DL, Chai S et al (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-676
25. NakamuraM, Asao H, Takeshita T, SugamuraK(1993) Interleukin-2 receptor heterotrimer complex and intracellular signaling. Semin Immunol 5:309-317
26. Francois C, Dantal J, Sorel M et al (1996) Antibodies directed at mouse IL-2-R alpha and beta chains act in synergy to abolish T cell proliferation in vitro and delayed type hypersensitivity reaction in vivo. Transpl Int 9:46-50
27. Yokoyama S, Watanabe N, Sato N et al (2009) Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A 106:15849-15854
28. Mathews CE, Graser RT, Bagley RJ et al (2003) Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress. Immunogenetics 55:491-496
29. Leiter EH, Reifsnyder PC, Wallace R, Li R, King B, Churchill GC (2009) NOD×129.H2(g7) backcross delineates 129S1/SvImJ-derived genomic regions modulating type 1 diabetes development in mice. Diabetes 58:1700-1703
30. Wicker LS, Todd JA, Prins JB, Podolin PL, Renjilian RJ, Peterson LB (1994) Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med 180:1705-1713
31. Cornelius JG, Luttge BG, Peck AB (1993) Antioxidant enzyme activities in IDD-prone and IDD-resistant mice: A comparative study. Free Radic Biol Med 14:409-420
32. Cao X, Shores EW, Hu-Li J et al (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2:223-238
33. Andre-Schmutz I, Hindelang C, Benoist C, Mathis D (1999) Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 29:245-255
34. Mathews CE, Suarez-Pinzon WL, Baust JJ, Strynadka K, Leiter EH, Rabinovitch A (2005) Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction. J Immunol 175:1248-1256
35. Suwanai H, Wilcox MA, Mathis D, Benoist C (2010) A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice. Proc Natl Acad Sci U S A 107:9305-9310
36. Rothe H, Hausmann A, Kolb H (2002) Immunoregulation during disease progression in prediabetic NOD mice: Inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15. Horm Metab Res 34:7-12
37. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266
38. Gary-Gouy H, Lebon P, Dalloul AH (2002) Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J Interferon Cytokine Res 22:653-659
39. Fujihira K, Nagata M, Moriyama H et al (2000) Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice. Diabetes 49:1998-2006
40. Li Q, McDevitt HO (2011) The role of interferon alpha in initiation of type I diabetes in the NOD mouse. Clin Immunol 140:3-7
41. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189:331-339
42. McGuire HM, Walters S, Vogelzang A et al (2011) Interleukin-21 is critically required in autoimmune and allogeneic responses to islet tissue in murine models. Diabetes 60:867-875
43. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ (2008) IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A 105:14028-14033
44. McGuire HM, Vogelzang A, Ma CS et al (2011) A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in autoimmunity. Immunity 34:602-615
45. Van Belle TL, Nierkens S, Arens R, von Herrath MG (2012) Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 34:1060-1072
46. Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 9:480-490
47. Miyagawa F, Tagaya Y, Kim BS et al (2008) IL-15 serves as a costimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft-versus-host-like disease. J Immunol 181:1109-1119
48. Goodyear M (2006) Learning from the TGN1412 trial. BMJ 332:677-678
49. Mathieu C, Gillard P (2011) Arresting type 1 diabetes after diagnosis: GAD is not enough. Lancet 378:291-292
50. Wherrett DK, Bundy B, Becker DJ et al (2011) Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: A randomised doubleblind trial. Lancet 378:319-327